X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
middle aged (15) 15
male (14) 14
aged (13) 13
female (13) 13
adult (11) 11
index medicus (11) 11
oncology (11) 11
human necessities (10) 10
hygiene (10) 10
medical or veterinary science (10) 10
microbiology (10) 10
preparations for medical, dental, or toilet purposes (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
chemistry (9) 9
culture media (9) 9
investigating or analysing materials by determining theirchemical or physical properties (9) 9
measuring (9) 9
metallurgy (9) 9
organic chemistry (9) 9
peptides (9) 9
physics (9) 9
testing (9) 9
beer (8) 8
biochemistry (8) 8
compositions thereof (8) 8
enzymology (8) 8
microorganisms or enzymes (8) 8
mutation or genetic engineering (8) 8
propagating, preserving or maintaining microorganisms (8) 8
spirits (8) 8
vinegar (8) 8
wine (8) 8
treatment outcome (7) 7
neoplasms - drug therapy (5) 5
antineoplastic agents - administration & dosage (4) 4
cancer (4) 4
chemotherapy (4) 4
cohort studies (4) 4
dose-response relationship, drug (4) 4
double-blind (4) 4
hematology (4) 4
medicine, research & experimental (4) 4
therapy (4) 4
activation (3) 3
animals (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
clinical trials (3) 3
colony-stimulating factor (3) 3
dosage and administration (3) 3
immunology (3) 3
infectious diseases (3) 3
infusions, intravenous (3) 3
interleukin-6 - administration & dosage (3) 3
interleukin-6 - adverse effects (3) 3
interleukin-6 - therapeutic use (3) 3
maximum tolerated dose (3) 3
pyrimidines - administration & dosage (3) 3
relapse (3) 3
research (3) 3
safety (3) 3
adolescent (2) 2
aged, 80 and over (2) 2
aids (2) 2
aids-related opportunistic infections - drug therapy (2) 2
amphotericin-b (2) 2
antifungals (2) 2
antigens (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antitumor-activity (2) 2
antiviral agents (2) 2
apoptosis-inducing ligand (2) 2
article (2) 2
azoles (2) 2
bone-marrow transplantation (2) 2
cancer-patients (2) 2
candidiasis (2) 2
candidiasis - drug therapy (2) 2
candidiasis, oral - drug therapy (2) 2
care and treatment (2) 2
cd4 antigen (2) 2
checkpoint kinase 1 (2) 2
cyclophosphamide (2) 2
cytarabine - administration & dosage (2) 2
dexamethasone - pharmacology (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
echocardiography (2) 2
efficacy (2) 2
genetic alterations (2) 2
growth hormone - genetics (2) 2
hematopoietic progenitors (2) 2
histones - metabolism (2) 2
hiv (2) 2
hiv infection (2) 2
hiv infections (2) 2
hiv infections - drug therapy (2) 2
hiv integrase inhibitors - administration & dosage (2) 2
hiv integrase inhibitors - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 12, pp. 907 - 915
Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 07/2017, Volume 9, Issue 399, p. eaaa0984
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2007, Volume 44, Issue 4, pp. 607 - 614
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 2, pp. 157 - 157
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2014, Volume 167, Issue 3, pp. 366 - 375
Dickkopf‐1 ( DKK 1), expressed by myeloma cells, suppresses osteoblast function and plays a key role in bone disease in multiple myeloma. BHQ 880, a human... 
880 | multiple myeloma | BHQ | Phase I | skeletal‐related event | BHQ880 | Multiple myeloma | Skeletal-related event | BONE-DISEASE | DICKKOPF-1 | skeletal-related event | DKK1 | IN-VITRO | SERUM CONCENTRATIONS | OSTEOBLASTS | GROWTH | DOUBLE-BLIND | RECEPTOR-RELATED PROTEIN-5 | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Recurrence | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Imidazoles - administration & dosage | Antibodies, Monoclonal - therapeutic use | Male | Neoplasm Proteins - antagonists & inhibitors | Osteolysis - etiology | Molecular Targeted Therapy | Osteolysis - drug therapy | Multiple Myeloma - drug therapy | Hypertension - chemically induced | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Diphosphonates - adverse effects | Anabolic Agents - therapeutic use | Bone Density Conservation Agents - adverse effects | Multiple Myeloma - complications | Imidazoles - adverse effects | Anabolic Agents - adverse effects | Bone Resorption - drug therapy | Antibodies, Monoclonal - pharmacokinetics | Bone Density Conservation Agents - therapeutic use | Fractures, Spontaneous - etiology | Diphosphonates - administration & dosage | Spinal Cord Compression - etiology | Bone Density Conservation Agents - administration & dosage | Bone Resorption - prevention & control | Maximum Tolerated Dose | Osteolysis - blood | Anabolic Agents - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Anabolic Agents - pharmacokinetics | Intercellular Signaling Peptides and Proteins - immunology | Medical research | Care and treatment | Relapse | Immunoglobulin G | Medicine, Experimental | Bones | Density | Diseases | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 9, pp. 1060 - 1066
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 03/2011, Volume 1222, Issue 1, pp. 83 - 89
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2018, Volume 36, Issue 3, pp. 276 - 282
Purpose No standard treatment exists for patients with cholangiocarcinoma for whom first-line gemcitabine-based therapy fails. Fibroblast growth factor... 
CRITERIA | ONCOLOGY | INHIBITOR | CANCER | INTRAHEPATIC CHOLANGIOCARCINOMAS | GENETIC ALTERATIONS | Index Medicus | ORIGINAL REPORTS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4086 - 4086
Journal Article
Journal Article
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2019, Volume 129, Issue 6, pp. 2210 - 2221
BACKGROUND. CAR T cells are a promising therapy for hematologic malignancies. B cell maturation antigen (BCMA) is a rational target in multiple myeloma (MM).... 
CD27 antigen | Antigens | Cytokines | CD8 antigen | Leukemia | Multiple myeloma | Clinical trials | Lymphocytes T | CD4 antigen | Signal transduction | Neurotoxicity | Cyclophosphamide | Leukapheresis | Chemotherapy | Lymphocytes B | Lymphocytes | Immunotherapy | Encephalopathy | Medical prognosis | Bone marrow | Lymphomas | Manufacturing | Candidemia | Drug dosages
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 109 - 109
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e22500 - e22500
Journal Article